- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Life Science & Biotech
Cook Group acquires local biotech company
April 9, 2012
IBJ StaffBloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company
with about 20 employees, Cook Group announced Monday.
MoreNew Lilly drug has small sales potential
April 9, 2012
J.K. WallEli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker
less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
MoreBiomet offers to acquire DePuy trauma biz for $280M
April 3, 2012
IBJ Staff and Bloomberg NewsWarsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal
would greatly expand its sports, extremities and trauma business.
MoreRoche's downsizing to claim about 80 local IT workers
March 29, 2012
IBJ StaffRoche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next
two years, the company said Thursday morning.
MoreDevice maker Biomet paying $22.7M to settle bribery case
March 26, 2012
Associated PressIndiana-based Biomet Inc. has agreed to pay $22.7 million to settle U.S. criminal and civil allegations that it bribed government-employed
doctors in Argentina, Brazil and China for eight years to win business with hospitals.
MoreQ&A
March 26, 2012
J.K. WallTino Pereira, CEO of Canada-based Iotron Industries, discussed the electron-beam facility his company opened
March 15 in Columbia City, which lies halfway between Fort Wayne and Warsaw in northern Indiana. Iotron already helps some
of the orthopedic implant makers in Warsaw alter the strength, flexibility or surface conditions of the materials in the joint
replacements they make. That makes its services important in research and development for new products.
MoreLilly receives Europe's OK for new Byetta use
March 23, 2012
IBJ Staff and Associated Press, Associated PressEuropean regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin
Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
MoreLife sciences firm plans to expand, add 46 jobs
March 15, 2012
Noblesville-based Helmer Inc. said it will invest $10.6 million to build a new manufacturing and headquarters facility at
the Saxony Corporate Campus near Interstate 69. It plans to add the jobs by 2014.
MoreEndocyte pulls trigger on European drug submission
March 13, 2012
J.K. WallEndocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after
the European Commission granted it orphan drug status.
MoreAIT Labs exec succeeding founder Evans as CEO
March 2, 2012
IBJ StaffThe promotions of several executives follow the Indianapolis-based clinical testing company's announcement in January that
it was cutting jobs and restructuring its business.
MoreCityWay designed to integrate retail, housing, hotel, YMCA
February 25, 2012
Marc D. AllanArchitects were told to push the envelope and integrate. Be mindful of where you are in the city and integrate well.
MoreEDITORIAL: BioCrossroads an example of vision at work
February 18, 2012
IBJ StaffWe hate to think what Indiana’s economic future might be if no one had made a point of putting the state’s life
sciences assets to work in a coordinated, strategic way.
MoreBioCrossroads has stoked state's life sciences industry, but challenges remain
February 11, 2012
J.K. WallIn the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies,
an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national
reports on life sciences.
MoreHealth care VC hits new Indiana low in 2011
February 6, 2012
J.K. WallIndiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to the
state’s health care sector since BioEnterprises began tracking such deals in 2005.
MoreDow Agro posts record fourth quarter profit
February 2, 2012
IBJ Staff and Associated PressThe Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the
$72 million reported for the 2010 period.
MoreLilly's quarterly profit tumbles, but tops Wall Street estimates
January 31, 2012
J.K. WallPatent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected
sales of other products.
MorePurdue hopes center simplifies commercialization
January 30, 2012
J.K. WallPurdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help
developing their research into products and for outside investors to find out what research is taking place there.
MoreEli Lilly unit plans to buy feed-enzyme maker
January 24, 2012
Associated PressDrugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products
that improve poultry, egg and meat production.
MoreIndianapolis-area mergers and acquisitions in 2011
January 21, 2012
A number of acquisitions last year disclosed no sale price. In the Indianapolis area, those deals ranged from MacAllister
Machinery's purchase of a Caterpillar dealership in Michigan to Herff Jones' acquisition of a Memphis, Tenn.-headquartered
maker of cheerleading uniforms.
MoreCity set to cancel tax abatement for medical device firm
January 18, 2012
Polymer Technology Systems said in 2007 that it would make a $3 million investment at its operation on Zionsville Road and
create 110 jobs.
MoreAt long last, Roche wins approval of Nano
January 16, 2012
J.K. WallThe OK for a new blood glucose monitor comes more than two years after FDA officials declined to approve a previous version
of the Nano, which in rare cases generated inflated blood sugar readings because it did not distinguish properly between the
sugars glucose and maltose.
MoreIndiana's medical device workforce will need skills upgrade
January 14, 2012
J.K. WallA new report by BioCrossroads says 53 percent of the 20,000 jobs in Indiana’s medical-device sector require no more
than a high school education.
MoreNational life sciences law firm opens office here
January 7, 2012
IBJ StaffNew York-based Epstein Becker Green already has clients here, including Biomet and Roche Diagnostics.
MoreEndocyte stays course despite being battered by investors
December 31, 2011
J.K. WallAfter spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West
Lafayette-based drug developer is in better position than ever.
MoreFiling: Roche considered leaving Indy
December 27, 2011
J.K. WallIt’s hard to believe now, but as recently as two years ago, Indianapolis was close to losing its 15th-largest employer.
Roche Diagnostics Corp. was looking seriously at moving its 2,900-employee North American headquarters out of Indianapolis.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
liek the rest of America
These quaint,obsessed musings by the stalkers are certainly entertaining, but I'm trying to figure out what, if anything, all the yelping below has to do with Zak Brown.
It's evident that Moffett was pushing the right buttons and corporate America is now trying to squash him. He just wanted to withdraw the free pilot services provided to the company by the pilots to try and put some pressure on a company that has not been interested in negotiating a contract in over 5 years. The company does not provide a contract because not having one has saved them a bundle of money. Shame on any Republic pilots not standing behind their union leader just because things are getting tough, can you not see such strategic moves by the company as putting the last union president in a corporate position and into THEIR pocket. Do you really believe the last union president is so appalled at the attempts by Moffett, do you not remember his oppositions to the company? We stood behind him. It has been proven over and over again for thousands of years without fail, a man cannot serve two masters. Anyone that believes people vote contrary to their paycheck and livelihood deserve to be taken advantage of, the recent statements by the former union president are laughable as he denounces the current union president from his new corporate position. Have you ever seen a drafted sports player score points for his previous team, it cannot be done, he is not on the pilots side anymore, he gets his money a different way now than you and I do, and he should not be allowed to remain on the seniority list. A drafted player brings strength, credibility, tactical knowledge, and a strategic advantage to his NEW team, he would not be drafted or paid were it otherwise. We are all forced to choose only one side to play for and support, not doing so has many references in life such as insider trading and shaving points, all illegal for good reason. This basic fact is why corporate moguls, scientist, and engineers all sign non-discloser agreements and non-compete clauses, as protection in case they are lured into switching sides as our former union president has done. No NFL coach ever drafted a player so that both teams could benefit and better understand each other, they are recruited to win the game against that former team, period. Likewise the company does not recruit the former union president by accident or mutual understanding, its strategy. Don't confuse playing the game with good sportsman-like conduct in support of common business and prosperity goals, with the requirement to only play for one side. Good men we all love and favor fall subject to this manipulation, often without their knowledge, and it is not a betrayal of their friendship to oppose them when they switch sides. If we did not love and trust them, they would not have been chosen and lured to the other side in the first place. The deception by the drafted player is not made at a conscious level, it's just human nature and it's all about money and power which corrupts our ability to be objective and loyal to two masters. This is why our court system created the defense attorney, and why our military created counter intelligence. Its strategy and its propaganda, and it works, and that's why the "powers to be" manipulate the chess pieces by sometimes changing their colors. Some players know they are being manipulated when their color is changed, but it brings them more money and power so they do not care. The rest have good intentions but do not even realize they are being manipulated. This tactic is also known by another name, Divide and Conquer. In battle sending an imperfect message with an imperfect team is obviously not ideal, but it's still being sent by YOUR team, your union leader, a leader that has common goals and common rewards with you, they are the best, because we have elected them to do a job for us. If you are not backing Moffett but believing the spin by those that have recently switched sides, you are taking food out of your own mouth. Showing unity and backing an imperfect situation still results in taking just as much ground, it's about unity and bargaining power. It's not necessary to wait around for that perfect attack because it will never come, the company will spin and attempt to destroy anyone that gets in their way. Ultimately it's not about any specific attack anyway, ASAP or whatever it makes no difference, it is and always has been only about power. If this company cared about safety it would not build pairings with 8 hour overnights, come on, are you that naive? Besides, do you really think Hoffa cares, no, he got a call from corporate America and was squeezed into denouncing Moffett. If he didn't they would spin the safety card against him and the Teamsters National with implication for truckers, future contracts, insurance rates etc...saying something like the Teamsters use safety as a bargaining chip, blah blah blah... Do you really think any pilot is going to do something unsafe for the contract, absolutely not, the only ones threatening safety here is the company with reduced rest, fatigue, and poverty. Do you not find it odd that Hoffa and the Teamsters are opposing a Teamster president publicly? Would the Teamsters National not normally support and work with one of their own? Why did they not sit down and help him strategize, correct any mistakes, and charge ahead? Would the Teamsters National not normally support and leverage a contract for all those pilots that have been paying Teamster dues, isn't that why we have all been paying Teamster dues in the first place? I sure haven't been paying dues so that the Teamsters National could come along and write this kind of an article undercutting our union leader and our unity. Whose side is the Teamsters National really on, it's obviously not the Republic pilots side.
No matter what Moffatt does the company is going to spin it like he is the terrorist and brainwash people like you into believing it, wake up, back your players that are trying to change things for you and your livelihood. Where has Hoffa been for the last 6 years, except collecting our dues. Seriously, do you really think an FO going for upgrade, signed off by a checkairman ready for the upgrade, who then fails, is not even capable of returning as a First Officer.
whoa!